Arthex Biotech Announces Oral Presentation On ATX-01 At TIDES Europe Annual Meeting 2024
VALENCIA, Spain, Nov. 11, 2024 /PRNewswire/ -- ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, today ...
Intra-Cellular to present at 2024 Psych Congress, NEI Congress
Therapies announced presentations about lumateperone including the results from Phase 3 adjunctive Major Depressive ...
ARTHEx Biotech Announces FDA Rare Pediatric Designation (RPD) of ATX-01 for the Treatment ...
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, today announced that the U.S. Food and Drug ...
Too Old to Operate5 天
Predictors of Abnormal Brain CT Findings in Mild Traumatic Brain Injury
The following is a summary of “Peri-injury symptomatology as predictors of brain computed tomography (CT) scan abnormalities ...